Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomarker
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
    Technologies and Software
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
SEPTEMBER 2021LIFE SCIENCES REVIEW4CONTENTS12COVER STORYPage 16 - 302531CXO INSIGHTSByron Flores, Global Head of Digital Finance, Data and Tools - Novartis Technical Operations, NovartisPatrik Florencio, SVP and Chief Compliance & Risk Officer andMichael Schneider, Vice President, Global Compliance Auditing and Monitoring, ERM, Amicus TherapeuticsIs Artificial Intelligence for Everybody?How Technology Enhances the Effectiveness of Compliance ProgramsBIOANALYTICALSERVICES COMPANIES IN UK - 2021TOP 5IMPROVING THE OVERALL EFFICIENCY OF CELL LINE DEVELOPMENT JEAN-MARC CAPPIA, HEAD OF CELL LINE, MEDIA AND TESTING
< Page 3 | Page 5 >